Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Blood-based Biomarker Market Research Report 2026

Global Blood-based Biomarker Market Research Report 2026

Industry: Medical Devices & Consumables

Published Date: 2026-03-11

Pages: 116 Pages

Report ld: 6198249

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Blood-based Biomarker Market Size(US$)

CAGR 2026-2032

10.4%

Market Size,2032

USD 3,977

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 2,203 million

Market Forecast in 2032(Value)

US$ 3,977 million

CAGR

10.4%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Blood-based Biomarker market was valued at US$ 2015 million in 2025 and is anticipated to reach US$ 3977 million by 2032, at a CAGR of 10.4% from 2026 to 2032.

A blood-based biomarker is a measurable biological molecule found in the blood that indicates normal or pathological processes in the body. These biomarkers can be proteins, nucleic acids, metabolites, or even circulating tumor cells that help diagnose diseases, monitor treatment responses, and predict patient outcomes. Blood-based biomarkers are widely used in oncology, neurology, and cardiovascular diseases, enabling early detection and personalized medicine approaches. Their non-invasive nature makes them highly valuable for routine clinical practice and research.

The North American market for Blood-based Biomarker is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Blood-based Biomarker is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Blood-based Biomarker in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Blood-based Biomarker include Roche Diagnostics, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Abbott, Siemens Healthineers, Danaher, Quidel Corporation, Grifols, Biocartis, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Blood-based Biomarker market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Blood-based Biomarker. The Blood-based Biomarker market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Blood-based Biomarker market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Blood-based Biomarker manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Roche Diagnostics
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Abbott
Siemens Healthineers
Danaher
Quidel Corporation
Grifols
Biocartis
Vernalis
Labcorp Drug Development

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Next Generation Sequencing
Mass Spectrometry
Liquid Biopsy Technologies

Segment by Application

Hospital
Diagnostic Centers
Research Labs

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Blood-based Biomarker companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Blood-based Biomarker Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Next Generation Sequencing

1.2.3 Mass Spectrometry

1.2.4 Liquid Biopsy Technologies

1.3 Market by Application

1.3.1 Global Blood-based Biomarker Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Diagnostic Centers

1.3.4 Research Labs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Blood-based Biomarker Market Perspective (2021–2032)

2.2 Global Blood-based Biomarker Growth Trends by Region

2.2.1 Global Blood-based Biomarker Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Blood-based Biomarker Historic Market Size by Region (2021–2026)

2.2.3 Blood-based Biomarker Forecasted Market Size by Region (2027–2032)

2.3 Blood-based Biomarker Market Dynamics

2.3.1 Blood-based Biomarker Industry Trends

2.3.2 Blood-based Biomarker Market Drivers

2.3.3 Blood-based Biomarker Market Challenges

2.3.4 Blood-based Biomarker Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Blood-based Biomarker Players by Revenue

3.1.1 Global Top Blood-based Biomarker Players by Revenue (2021–2026)

3.1.2 Global Blood-based Biomarker Revenue Market Share by Players (2021–2026)

3.2 Global Top Blood-based Biomarker Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Blood-based Biomarker Revenue

3.4 Global Blood-based Biomarker Market Concentration Ratio

3.4.1 Global Blood-based Biomarker Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Blood-based Biomarker Revenue in 2025

3.5 Global Key Players of Blood-based Biomarker Head Offices and Areas Served

3.6 Global Key Players of Blood-based Biomarker, Products and Applications

3.7 Global Key Players of Blood-based Biomarker, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Blood-based Biomarker Breakdown Data by Type

4.1 Global Blood-based Biomarker Historic Market Size by Type (2021–2026)

4.2 Global Blood-based Biomarker Forecasted Market Size by Type (2027–2032)

5 Blood-based Biomarker Breakdown Data by Application

5.1 Global Blood-based Biomarker Historic Market Size by Application (2021–2026)

5.2 Global Blood-based Biomarker Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Blood-based Biomarker Market Size (2021–2032)

6.2 North America Blood-based Biomarker Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Blood-based Biomarker Market Size by Country (2021–2026)

6.4 North America Blood-based Biomarker Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Blood-based Biomarker Market Size (2021–2032)

7.2 Europe Blood-based Biomarker Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Blood-based Biomarker Market Size by Country (2021–2026)

7.4 Europe Blood-based Biomarker Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Blood-based Biomarker Market Size (2021–2032)

8.2 Asia-Pacific Blood-based Biomarker Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Blood-based Biomarker Market Size by Region (2021–2026)

8.4 Asia-Pacific Blood-based Biomarker Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Blood-based Biomarker Market Size (2021–2032)

9.2 Latin America Blood-based Biomarker Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Blood-based Biomarker Market Size by Country (2021–2026)

9.4 Latin America Blood-based Biomarker Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Blood-based Biomarker Market Size (2021–2032)

10.2 Middle East & Africa Blood-based Biomarker Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Blood-based Biomarker Market Size by Country (2021–2026)

10.4 Middle East & Africa Blood-based Biomarker Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche Diagnostics

11.1.1 Roche Diagnostics Company Details

11.1.2 Roche Diagnostics Business Overview

11.1.3 Roche Diagnostics Blood-based Biomarker Introduction

11.1.4 Roche Diagnostics Revenue in Blood-based Biomarker Business (2021–2026)

11.1.5 Roche Diagnostics Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Details

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Blood-based Biomarker Introduction

11.2.4 Thermo Fisher Scientific Revenue in Blood-based Biomarker Business (2021–2026)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 Bio-Rad Laboratories

11.3.1 Bio-Rad Laboratories Company Details

11.3.2 Bio-Rad Laboratories Business Overview

11.3.3 Bio-Rad Laboratories Blood-based Biomarker Introduction

11.3.4 Bio-Rad Laboratories Revenue in Blood-based Biomarker Business (2021–2026)

11.3.5 Bio-Rad Laboratories Recent Development

11.4 Qiagen

11.4.1 Qiagen Company Details

11.4.2 Qiagen Business Overview

11.4.3 Qiagen Blood-based Biomarker Introduction

11.4.4 Qiagen Revenue in Blood-based Biomarker Business (2021–2026)

11.4.5 Qiagen Recent Development

11.5 Abbott

11.5.1 Abbott Company Details

11.5.2 Abbott Business Overview

11.5.3 Abbott Blood-based Biomarker Introduction

11.5.4 Abbott Revenue in Blood-based Biomarker Business (2021–2026)

11.5.5 Abbott Recent Development

11.6 Siemens Healthineers

11.6.1 Siemens Healthineers Company Details

11.6.2 Siemens Healthineers Business Overview

11.6.3 Siemens Healthineers Blood-based Biomarker Introduction

11.6.4 Siemens Healthineers Revenue in Blood-based Biomarker Business (2021–2026)

11.6.5 Siemens Healthineers Recent Development

11.7 Danaher

11.7.1 Danaher Company Details

11.7.2 Danaher Business Overview

11.7.3 Danaher Blood-based Biomarker Introduction

11.7.4 Danaher Revenue in Blood-based Biomarker Business (2021–2026)

11.7.5 Danaher Recent Development

11.8 Quidel Corporation

11.8.1 Quidel Corporation Company Details

11.8.2 Quidel Corporation Business Overview

11.8.3 Quidel Corporation Blood-based Biomarker Introduction

11.8.4 Quidel Corporation Revenue in Blood-based Biomarker Business (2021–2026)

11.8.5 Quidel Corporation Recent Development

11.9 Grifols

11.9.1 Grifols Company Details

11.9.2 Grifols Business Overview

11.9.3 Grifols Blood-based Biomarker Introduction

11.9.4 Grifols Revenue in Blood-based Biomarker Business (2021–2026)

11.9.5 Grifols Recent Development

11.10 Biocartis

11.10.1 Biocartis Company Details

11.10.2 Biocartis Business Overview

11.10.3 Biocartis Blood-based Biomarker Introduction

11.10.4 Biocartis Revenue in Blood-based Biomarker Business (2021–2026)

11.10.5 Biocartis Recent Development

11.11 Vernalis

11.11.1 Vernalis Company Details

11.11.2 Vernalis Business Overview

11.11.3 Vernalis Blood-based Biomarker Introduction

11.11.4 Vernalis Revenue in Blood-based Biomarker Business (2021–2026)

11.11.5 Vernalis Recent Development

11.12 Labcorp Drug Development

11.12.1 Labcorp Drug Development Company Details

11.12.2 Labcorp Drug Development Business Overview

11.12.3 Labcorp Drug Development Blood-based Biomarker Introduction

11.12.4 Labcorp Drug Development Revenue in Blood-based Biomarker Business (2021–2026)

11.12.5 Labcorp Drug Development Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Blood-based Biomarker Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Next Generation Sequencing

Table 3. Key Players of Mass Spectrometry

Table 4. Key Players of Liquid Biopsy Technologies

Table 5. Global Blood-based Biomarker Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Blood-based Biomarker Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Blood-based Biomarker Market Size by Region (US$ Million), 2021–2026

Table 8. Global Blood-based Biomarker Market Share by Region (2021–2026)

Table 9. Global Blood-based Biomarker Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Blood-based Biomarker Market Share by Region (2027–2032)

Table 11. Blood-based Biomarker Market Trends

Table 12. Blood-based Biomarker Market Drivers

Table 13. Blood-based Biomarker Market Challenges

Table 14. Blood-based Biomarker Market Restraints

Table 15. Global Blood-based Biomarker Revenue by Players (US$ Million), 2021–2026

Table 16. Global Blood-based Biomarker Market Share by Players (2021–2026)

Table 17. Global Top Blood-based Biomarker Players by Tier (Tier 1, Tier 2, and Tier 3), based on Blood-based Biomarker Revenue, 2025

Table 18. Ranking of Global Top Blood-based Biomarker Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Blood-based Biomarker Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Blood-based Biomarker, Headquarters and Area Served

Table 21. Global Key Players of Blood-based Biomarker, Products and Applications

Table 22. Global Key Players of Blood-based Biomarker, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Blood-based Biomarker Market Size by Type (US$ Million), 2021–2026

Table 25. Global Blood-based Biomarker Revenue Market Share by Type (2021–2026)

Table 26. Global Blood-based Biomarker Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Blood-based Biomarker Revenue Market Share by Type (2027–2032)

Table 28. Global Blood-based Biomarker Market Size by Application (US$ Million), 2021–2026

Table 29. Global Blood-based Biomarker Revenue Market Share by Application (2021–2026)

Table 30. Global Blood-based Biomarker Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Blood-based Biomarker Revenue Market Share by Application (2027–2032)

Table 32. North America Blood-based Biomarker Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Blood-based Biomarker Market Size by Country (US$ Million), 2021–2026

Table 34. North America Blood-based Biomarker Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Blood-based Biomarker Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Blood-based Biomarker Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Blood-based Biomarker Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Blood-based Biomarker Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Blood-based Biomarker Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Blood-based Biomarker Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Blood-based Biomarker Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Blood-based Biomarker Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Blood-based Biomarker Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Blood-based Biomarker Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Blood-based Biomarker Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Blood-based Biomarker Market Size by Country (US$ Million), 2027–2032

Table 47. Roche Diagnostics Company Details

Table 48. Roche Diagnostics Business Overview

Table 49. Roche Diagnostics Blood-based Biomarker Product

Table 50. Roche Diagnostics Revenue in Blood-based Biomarker Business (US$ Million), 2021–2026

Table 51. Roche Diagnostics Recent Development

Table 52. Thermo Fisher Scientific Company Details

Table 53. Thermo Fisher Scientific Business Overview

Table 54. Thermo Fisher Scientific Blood-based Biomarker Product

Table 55. Thermo Fisher Scientific Revenue in Blood-based Biomarker Business (US$ Million), 2021–2026

Table 56. Thermo Fisher Scientific Recent Development

Table 57. Bio-Rad Laboratories Company Details

Table 58. Bio-Rad Laboratories Business Overview

Table 59. Bio-Rad Laboratories Blood-based Biomarker Product

Table 60. Bio-Rad Laboratories Revenue in Blood-based Biomarker Business (US$ Million), 2021–2026

Table 61. Bio-Rad Laboratories Recent Development

Table 62. Qiagen Company Details

Table 63. Qiagen Business Overview

Table 64. Qiagen Blood-based Biomarker Product

Table 65. Qiagen Revenue in Blood-based Biomarker Business (US$ Million), 2021–2026

Table 66. Qiagen Recent Development

Table 67. Abbott Company Details

Table 68. Abbott Business Overview

Table 69. Abbott Blood-based Biomarker Product

Table 70. Abbott Revenue in Blood-based Biomarker Business (US$ Million), 2021–2026

Table 71. Abbott Recent Development

Table 72. Siemens Healthineers Company Details

Table 73. Siemens Healthineers Business Overview

Table 74. Siemens Healthineers Blood-based Biomarker Product

Table 75. Siemens Healthineers Revenue in Blood-based Biomarker Business (US$ Million), 2021–2026

Table 76. Siemens Healthineers Recent Development

Table 77. Danaher Company Details

Table 78. Danaher Business Overview

Table 79. Danaher Blood-based Biomarker Product

Table 80. Danaher Revenue in Blood-based Biomarker Business (US$ Million), 2021–2026

Table 81. Danaher Recent Development

Table 82. Quidel Corporation Company Details

Table 83. Quidel Corporation Business Overview

Table 84. Quidel Corporation Blood-based Biomarker Product

Table 85. Quidel Corporation Revenue in Blood-based Biomarker Business (US$ Million), 2021–2026

Table 86. Quidel Corporation Recent Development

Table 87. Grifols Company Details

Table 88. Grifols Business Overview

Table 89. Grifols Blood-based Biomarker Product

Table 90. Grifols Revenue in Blood-based Biomarker Business (US$ Million), 2021–2026

Table 91. Grifols Recent Development

Table 92. Biocartis Company Details

Table 93. Biocartis Business Overview

Table 94. Biocartis Blood-based Biomarker Product

Table 95. Biocartis Revenue in Blood-based Biomarker Business (US$ Million), 2021–2026

Table 96. Biocartis Recent Development

Table 97. Vernalis Company Details

Table 98. Vernalis Business Overview

Table 99. Vernalis Blood-based Biomarker Product

Table 100. Vernalis Revenue in Blood-based Biomarker Business (US$ Million), 2021–2026

Table 101. Vernalis Recent Development

Table 102. Labcorp Drug Development Company Details

Table 103. Labcorp Drug Development Business Overview

Table 104. Labcorp Drug Development Blood-based Biomarker Product

Table 105. Labcorp Drug Development Revenue in Blood-based Biomarker Business (US$ Million), 2021–2026

Table 106. Labcorp Drug Development Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Blood-based Biomarker Picture

Figure 2. Global Blood-based Biomarker Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Blood-based Biomarker Market Share by Type: 2025 vs 2032

Figure 4. Next Generation Sequencing Features

Figure 5. Mass Spectrometry Features

Figure 6. Liquid Biopsy Technologies Features

Figure 7. Global Blood-based Biomarker Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Blood-based Biomarker Market Share by Application: 2025 vs 2032

Figure 9. Hospital Case Studies

Figure 10. Diagnostic Centers Case Studies

Figure 11. Research Labs Case Studies

Figure 12. Blood-based Biomarker Report Years Considered

Figure 13. Global Blood-based Biomarker Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Blood-based Biomarker Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Blood-based Biomarker Market Share by Region: 2025 vs 2032

Figure 16. Global Blood-based Biomarker Market Share by Players in 2025

Figure 17. Global Blood-based Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Blood-based Biomarker Revenue in 2025

Figure 19. North America Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Blood-based Biomarker Market Share by Country (2021–2032)

Figure 21. United States Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Blood-based Biomarker Market Share by Country (2021–2032)

Figure 25. Germany Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Blood-based Biomarker Market Share by Region (2021–2032)

Figure 33. China Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Blood-based Biomarker Market Share by Country (2021–2032)

Figure 41. Mexico Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Blood-based Biomarker Market Share by Country (2021–2032)

Figure 45. Israel Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Blood-based Biomarker Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Roche Diagnostics Revenue Growth Rate in Blood-based Biomarker Business (2021–2026)

Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Blood-based Biomarker Business (2021–2026)

Figure 50. Bio-Rad Laboratories Revenue Growth Rate in Blood-based Biomarker Business (2021–2026)

Figure 51. Qiagen Revenue Growth Rate in Blood-based Biomarker Business (2021–2026)

Figure 52. Abbott Revenue Growth Rate in Blood-based Biomarker Business (2021–2026)

Figure 53. Siemens Healthineers Revenue Growth Rate in Blood-based Biomarker Business (2021–2026)

Figure 54. Danaher Revenue Growth Rate in Blood-based Biomarker Business (2021–2026)

Figure 55. Quidel Corporation Revenue Growth Rate in Blood-based Biomarker Business (2021–2026)

Figure 56. Grifols Revenue Growth Rate in Blood-based Biomarker Business (2021–2026)

Figure 57. Biocartis Revenue Growth Rate in Blood-based Biomarker Business (2021–2026)

Figure 58. Vernalis Revenue Growth Rate in Blood-based Biomarker Business (2021–2026)

Figure 59. Labcorp Drug Development Revenue Growth Rate in Blood-based Biomarker Business (2021–2026)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Blood-based Biomarker in 2032? zhanKai

The global market size of Blood-based Biomarker in 2032 was 3977 Million USD.

Which companies rank high in the global Blood-based Biomarker market? shouQi

What was the global market size of Blood-based Biomarker in 2026? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Blood-based Biomarker market size from 2026 to 2032? shouQi

Related Reports

Global Blood-based Biomarker Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Blood-based Biomarker market is projected to grow from US$ 2015 million in 2025 to US$ 3977 million by 2032, at a CAGR of 10.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-11
Pages: 140
USD 4900.00
(Single User License)
Global Blood-based Biomarker Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Blood-based Biomarker market size was US$ 2015 million in 2025 and is forecast to reach a readjusted size of US$ 3977 million by 2032 with a CAGR of 10.4% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 97
USD 4250.00
(Single User License)
Blood-based Biomarker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Blood-based Biomarker was estimated to be worth US$ 2015 million in 2025 and is projected to reach US$ 3977 million, growing at a CAGR of 10.4% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 104
USD 3950.00
(Single User License)
Global Blood-based Biomarker Market Insights, Forecast to 2031
The global Blood-based Biomarker market is projected to grow from US$ 2015 million in 2025 to US$ 3638 million by 2031, at a Compound Annual Growth Rate (CAGR) of 10.4% during the forecast period.
Published Date: 2025-03-28
Pages: 143
USD 4900.00
(Single User License)
Global Blood-based Biomarker Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Blood-based Biomarker market size was US$ 1867 million in 2024 and is forecast to a readjusted size of US$ 3638 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 92
USD 4250.00
(Single User License)
Blood-based Biomarker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Blood-based Biomarker was estimated to be worth US$ 1867 million in 2024 and is forecast to a readjusted size of US$ 3638 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 101
USD 3950.00
(Single User License)
Global Blood-based Biomarker Market Research Report 2025
The global market for Blood-based Biomarker was valued at US$ 1867 million in the year 2024 and is projected to reach a revised size of US$ 3638 million by 2031, growing at a CAGR of 10.4% during the forecast period.
Published Date: 2025-03-28
Pages: 85
USD 2900.00
(Single User License)

Global Blood-based Biomarker Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Blood-based Biomarker market is projected to grow from US$ 2015 million in 2025 to US$ 3977 million by 2032, at a CAGR of 10.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 140
USD 4900.00 (Single User License)
Global Blood-based Biomarker Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Blood-based Biomarker market size was US$ 2015 million in 2025 and is forecast to reach a readjusted size of US$ 3977 million by 2032 with a CAGR of 10.4% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 97
USD 4250.00 (Single User License)
Blood-based Biomarker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Blood-based Biomarker was estimated to be worth US$ 2015 million in 2025 and is projected to reach US$ 3977 million, growing at a CAGR of 10.4% from 2026 to 2032.
Published: 2026-03-09
Pages: 104
USD 3950.00 (Single User License)
Global Blood-based Biomarker Market Insights, Forecast to 2031
The global Blood-based Biomarker market is projected to grow from US$ 2015 million in 2025 to US$ 3638 million by 2031, at a Compound Annual Growth Rate (CAGR) of 10.4% during the forecast period.
Published: 2025-03-28
Pages: 143
USD 4900.00 (Single User License)
Global Blood-based Biomarker Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Blood-based Biomarker market size was US$ 1867 million in 2024 and is forecast to a readjusted size of US$ 3638 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 92
USD 4250.00 (Single User License)
Blood-based Biomarker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Blood-based Biomarker was estimated to be worth US$ 1867 million in 2024 and is forecast to a readjusted size of US$ 3638 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 101
USD 3950.00 (Single User License)
Global Blood-based Biomarker Market Research Report 2025
The global market for Blood-based Biomarker was valued at US$ 1867 million in the year 2024 and is projected to reach a revised size of US$ 3638 million by 2031, growing at a CAGR of 10.4% during the forecast period.
Published: 2025-03-28
Pages: 85
USD 2900.00 (Single User License)